Publicacións nas que colabora con Fabrizio D'Ascenzo (48)

2024

  1. Corrigendum to ‘Forecasting the Risk of Heart Failure Hospitalization After Acute Coronary Syndromes: the CORALYS HF Score’ [American Journal of Cardiology 206 (2023) 320-329, (S000291492300766X), (10.1016/j.amjcard.2023.08.010)]

    American Journal of Cardiology

  2. Gender differences in the development of heart failure after acute coronary syndrome: Insight from the CORALYS registry

    International Journal of Cardiology, Vol. 397

  3. Long-term impact of intravascular ultrasound-guidance for percutaneous coronary intervention on unprotected left main. The IMPACTUS-LM, an observational, multicentric study

    International Journal of Cardiology, Vol. 401

2023

  1. Forecasting the Risk of Heart Failure Hospitalization After Acute Coronary Syndromes: the CORALYS HF Score

    American Journal of Cardiology, Vol. 206, pp. 320-329

  2. Impact of Complete Revascularization on Development of Heart Failure in Patients With Acute Coronary Syndrome and Multivessel Disease: A Subanalysis of the CORALYS Registry

    Journal of the American Heart Association, Vol. 12, Núm. 15, pp. e028475

  3. Impact of Right Ventricular Pacing in Patients With TAVR Undergoing Permanent Pacemaker Implantation

    JACC: Cardiovascular Interventions, Vol. 16, Núm. 9, pp. 1081-1091

  4. IncidenCe and predictOrs of heaRt fAiLure after acute coronarY Syndrome: The CORALYS registry

    International Journal of Cardiology, Vol. 370, pp. 35-42

  5. Optimal medical therapy improves outcomes in patients with diabetes mellitus and acute myocardial infarction

    Diabetes Research and Clinical Practice, Vol. 203

  6. Predictors of target lesion failure after treatment of left main, bifurcation, or chronic total occlusion lesions with ultrathin-strut drug-eluting coronary stents in the ULTRA registry

    Catheterization and Cardiovascular Interventions, Vol. 102, Núm. 2, pp. 221-232

2022

  1. Ischemic-hemorrhagic balance in diabetic and non-diabetic patients after acute coronary syndrome

    REC: CardioClinics, Vol. 57, Núm. 3, pp. 203-211

  2. Safety and efficacy of different P2Y12 inhibitors in patients with acute coronary syndromes stratified by the PRAISE risk score: a multicentre study

    European heart journal. Quality of care & clinical outcomes, Vol. 8, Núm. 8, pp. 881-891

2021

  1. Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registry

    Revista Espanola de Cardiologia, Vol. 74, Núm. 7, pp. 608-615

  2. Evaluation of optimal medical therapy in acute myocardial infarction patients with prior stroke

    Therapeutic Advances in Chronic Disease, Vol. 12

  3. Long-term (≥15 years) Follow-up of Percutaneous Coronary Intervention of Unprotected Left Main (From the GRAVITY Registry)

    American Journal of Cardiology, Vol. 156, pp. 72-78

  4. Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets

    The Lancet, Vol. 397, Núm. 10270, pp. 199-207

  5. Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry

    Internal and Emergency Medicine, Vol. 16, Núm. 4, pp. 957-966

  6. Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational Registries

    Cardiovascular Drugs and Therapy, Vol. 35, Núm. 6, pp. 1171-1182

  7. Ticagrelor versus prasugrel in acute coronary syndrome: sex-specific analysis from the RENAMI Registry

    Minerva cardiology and angiology, Vol. 69, Núm. 4, pp. 408-416

  8. Underlying heart diseases and acute covid-19 outcomes

    Cardiology Journal, Vol. 28, Núm. 2, pp. 202-214

2020

  1. Antithrombotic Therapy in Patients With Prior Stroke/Transient Ischemic Attack and Acute Coronary Syndromes

    Angiology